Hologic, Inc. (HOLX) Stock Price Today
Key Stats
- $16.97BMarket Cap
- -Volume
- HealthSector
- $76.0152W High
- $62.0152W Low
- 60 DaysTypical Hold Time
- $17.12BEnterprise Value
- -Div Yield
- -Trading Activity
Track Hologic, Inc. (HOLX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Hologic, Inc. has traded between a low of $62.01 and a high of $76.01, highlighting its annual price range. Buy and sell Hologic, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Hologic, Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Most Recent News
Pacira BioSciences downgraded after Viatris announces $1.65B acquisition deal.
Pacira BioSciences was downgraded from Buy to Hold by Needham following Viatris's announcement to acquire the company for $36.50 per share, valuing it at about $1.65 billion. The deal is expected to close by late 2026 and will enhance Viatris's portf...
CIQ launches Fuzzball 4.3 for easy AI model deployment on existing GPU infrastructure
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
Vanguard FTSE Pacific ETF gains 26% YTD, supported by strong APAC earnings and attractive valuation.
The Vanguard FTSE Pacific ETF (VPL) has risen 26% year-to-date, driven by compelling valuation and strong earnings growth in the Asia-Pacific region. Trading at a low price-to-earnings ratio of 12.2 with an 11.6% long-term earnings growth rate, the E...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.